Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
Benign cephalic histiocytosis.
Joan F Samson1, Gnanaseelan Kanakamma Libu2, Mariam Philip1
1Department of Dermatology and Venereology, Dr. SMCSI Medical College, Karakonam, Trivandrum, Kerala, India.
Benign cephalic histiocytosis is a rare skin condition presenting as asymptomatic papules on the face. Diagnosis in this pediatric case was confirmed through clinical examination, histopathology, and immunohistochemistry.
Area of Science:
- Dermatology
- Pediatric Dermatology
- Histopathology
Background:
- Benign cephalic histiocytosis (BCH) is a rare, self-limiting cutaneous disorder primarily affecting infants and young children.
- It is characterized by the idiopathic proliferation of histiocytes in the dermis, typically presenting on the face.
Observation:
- A one-and-a-half-year-old girl presented with a year-long history of gradually increasing, asymptomatic papules on both cheeks.
- The lesions varied in color from erythematous to hyperpigmented and skin-colored.
Findings:
- Clinical examination revealed multiple facial papules consistent with a histiocytic proliferation.
- Histopathological examination and immunohistochemistry confirmed the diagnosis of benign cephalic histiocytosis.
Implications:
- This case highlights the importance of considering benign cephalic histiocytosis in the differential diagnosis of pediatric facial papules.
- Accurate diagnosis through multimodal assessment (clinical, histopathological, immunohistochemical) is crucial for appropriate management and reassurance.
- Understanding the benign and self-limiting nature of BCH is important for avoiding unnecessary treatments.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
Cytomegalovirus Disease
Encephalitis l: Introduction
Cytotoxic Edema: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy